Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the “Company”) announced today that the TSX Venture Exchange (the “Exchange”) has accepted…
Investigational T-cell engager, surovatamig, and CAR T-cell therapy, AZD0120, will show potential with initial data across multiple blood cancers New…
First and Only Cochlear Implant FDA Approved for Youngest Infant Population DURHAM, N.C.–(BUSINESS WIRE)–#FDAapproval–MED-EL USA announced today that the U.S.…
CHÂTILLON, France–(BUSINESS WIRE)–Orano Med, a subsidiary of the Orano Group specializing in nuclear medicine, announced today that its long-standing collaboration…
The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to…
BAY 3401016 is an investigational monoclonal antibody with potential to block a protein called Semaphorin 3A (Sema3A), which is thought…
Advancing cold chain technology with enhanced medication safety and energy efficiency BROOMFIELD, Colo.–(BUSINESS WIRE)–Swisslog Healthcare, a leading supplier in transport…
DUBLIN–(BUSINESS WIRE)–The “Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill…
Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast…
In vitro studies show reductions in key inflammatory and fibrotic markers and signs of pro-regenerative activity SAN FRANCISCO–(BUSINESS WIRE)–Animate Biosciences…